Clinical Research Directory
Browse clinical research sites, groups, and studies.
Mobile Chat Messaging for Alcohol Reduction in Patients With Chronic Liver Diseases
Sponsor: The University of Hong Kong
Summary
The goal of this pilot randomized controlled trial is to evaluate the trial feasibility and acceptability of mobile chat messaging for reducing alcohol use among patients with chronic liver diseases. Specific objectives include: 1. To assess whether the eligibility criteria were too restrictive by estimating the eligibility rate 2. To assess how many eligible CLD patients accepted the invitation to participate in the trial 3. To assess the participant retention rate through 6 months after treatment initiation 4. To assess the intervention acceptability in terms of participants' engagement with and rating of the chat messaging intervention. 5. To assess the safety of the intervention 6. To estimate the intervention effect on alcohol use outcomes and liver functions 7. To synthesise data to inform the sample size calculation in the future definitive trial 8. To explore the participants' perception and experiences in the chat-based intervention
Official title: Mobile Chat Messaging Plus Screening-based Brief Alcohol Intervention for Patients With Chronic Liver Diseases: a Pilot Randomised Controlled Trial
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
106
Start Date
2024-10-02
Completion Date
2025-12-31
Last Updated
2025-05-01
Healthy Volunteers
No
Conditions
Interventions
Mobile chat messaging
A trained counsellor will interact with a participant individually and provide personalised alcohol reduction information and advice via a mobile instant messaging app in real time for 3 months from randomisation.
Screening, brief intervention and referral to treatment
Brief counselling (5 to 10 mins) to reduce drinking and a self-help booklet
Locations (1)
Queen Mary Hospital
Hong Kong, Hong Kong